|
Clinical Trials and Observations
Citations 321-330 of 2742 total displayed.
|
Past content
(since May 1998):
|
Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis
- Maria E. Sarasquete, Ramon García-Sanz, Luis Marín, Miguel Alcoceba, Maria C. Chillón, Ana Balanzategui, Carlos Santamaria, Laura Rosiñol, Javier de la Rubia, Miguel T. Hernandez, Inmaculada Garcia-Navarro, Juan J. Lahuerta, Marcos González, and Jesus F. San Miguel
Blood 2008; 112: 2709-2712.
[Abstract]
[Full text]
[PDF]
Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes
- Vinod K. Prasad, Adam Mendizabal, Suhag H. Parikh, Paul Szabolcs, Timothy A. Driscoll, Kristin Page, Sonali Lakshminarayanan, June Allison, Susan Wood, Deborah Semmel, Maria L. Escolar, Paul L. Martin, Shelly Carter, and Joanne Kurtzberg
Blood 2008; 112: 2979-2989.
[Abstract]
[Full text]
[PDF]
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
- Ola Landgren, Lynn R. Goldin, Sigurdur Y. Kristinsson, Elin A. Helgadottir, Jan Samuelsson, and Magnus Björkholm
Blood 2008; 112: 2199-2204.
[Abstract]
[Full text]
[PDF]
How I treat cobalamin (vitamin B12) deficiency
- Ralph Carmel
Blood 2008; 112: 2214-2221.
[Abstract]
[Full text]
[PDF]
Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies
- Jeff K. Davies, John G. Gribben, Lisa L. Brennan, Dongin Yuk, Lee M. Nadler, and Eva C. Guinan
Blood 2008; 112: 2232-2241.
[Abstract]
[Full text]
[PDF]
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
- Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, and Annelise Segers, on behalf of the Einstein–DVT Dose-Ranging Study investigators
Blood 2008; 112: 2242-2247.
[Abstract]
[Full text]
[PDF]
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
- Graham M. Mead, Sharon L. Barrans, Wendi Qian, Jan Walewski, John A. Radford, Max Wolf, Simon M. Clawson, Sally P. Stenning, Claire L. Yule, and Andrew S. Jack, on behalf of the UK National Cancer Research Institute Lymphoma Clinical Studies Group and the Australasian Leukaemia and Lymphoma Group
Blood 2008; 112: 2248-2260.
[Abstract]
[Full text]
[PDF]
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
- Brian G. Till, Michael C. Jensen, Jinjuan Wang, Eric Y. Chen, Brent L. Wood, Harvey A. Greisman, Xiaojun Qian, Scott E. James, Andrew Raubitschek, Stephen J. Forman, Ajay K. Gopal, John M. Pagel, Catherine G. Lindgren, Philip D. Greenberg, Stanley R. Riddell, and Oliver W. Press
Blood 2008; 112: 2261-2271.
[Abstract]
[Full text]
[PDF]
Soluble CD22 as a tumor marker for hairy cell leukemia
- Kakushi Matsushita, Inger Margulies, Masanori Onda, Satoshi Nagata, Maryalice Stetler-Stevenson, and Robert J. Kreitman
Blood 2008; 112: 2272-2277.
[Abstract]
[Full text]
[PDF]
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR- receptor
- Julie H. Lin, Ellen J. Kim, Anand Bansal, John Seykora, Stephen K. Richardson, Xian-Yuan Cha, Sarosh Zafar, Sunita Nasta, Maria Wysocka, Bernice Benoit, Alain H. Rook, and Steven S. Fakharzadeh
Blood 2008; 112: 2484-2488.
[Abstract]
[Full text]
[PDF]
|
|
